A detailed history of Parallax Volatility Advisers, L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 837,287 shares of TEVA stock, worth $14.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
837,287
Previous 100 837187.0%
Holding current value
$14.3 Million
Previous $1,000 1360400.0%
% of portfolio
0.03%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $10.7 Million - $14.6 Million
837,287 New
837,287 $13.6 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $1.25 Million - $1.64 Million
-154,356 Reduced 30.12%
358,040 $3.74 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $2.97 Million - $4.25 Million
-397,552 Reduced 43.69%
512,396 $5.23 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $1.47 Million - $1.93 Million
203,814 Added 28.86%
909,948 $6.85 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $2.26 Million - $3.07 Million
-270,395 Reduced 27.69%
706,134 $6.25 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $1.73 Million - $2.07 Million
-218,101 Reduced 18.26%
976,529 $8.91 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $4.58 Million - $7.98 Million
667,636 Added 126.69%
1,194,630 $9.64 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $1.09 Million - $1.53 Million
147,118 Added 38.73%
526,994 $3.96 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $2.78 Million - $3.57 Million
379,876 New
379,876 $3.57 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $2.11 Million - $2.72 Million
-267,113 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $624,502 - $805,529
79,051 Added 42.03%
267,113 $2.14 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $1.58 Million - $1.91 Million
188,062 New
188,062 $1.83 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $303,506 - $368,699
-36,218 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $358,558 - $418,680
36,218 New
36,218 $359,000
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $4.17 Million - $5.17 Million
-403,639 Reduced 91.47%
37,639 $434,000
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $389,187 - $482,155
-37,639 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $3.8 Million - $4.87 Million
441,278 New
441,278 $4.26 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $4.53 Million - $5.8 Million
-525,560 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $3.35 Million - $4.96 Million
-390,931 Reduced 42.66%
525,560 $4.74 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $2.4 Million - $3.88 Million
295,493 Added 47.58%
916,491 $11.3 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $949,150 - $1.91 Million
-141,876 Reduced 18.6%
620,998 $5.58 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $2.93 Million - $4.81 Million
449,053 Added 143.09%
762,874 $7.48 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $367,782 - $573,168
-59,705 Reduced 15.98%
313,821 $2.16 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $1.54 Million - $2.99 Million
190,190 Added 103.74%
373,526 $3.45 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $1.45 Million - $1.86 Million
92,871 Added 102.66%
183,336 $2.88 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $922,146 - $1.51 Million
63,204 Added 231.85%
90,465 $1.4 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $6.4 Million - $7.8 Million
-303,920 Reduced 91.77%
27,261 $587,000
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $5.88 Million - $8.66 Million
-350,463 Reduced 51.41%
331,181 $8.05 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $8.05 Million - $10.7 Million
482,747 Added 242.71%
681,644 $11.6 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $2.23 Million - $3.8 Million
198,897
198,897 $3.77 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.